Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/18/2026

1. NFLX
2. ISRG
3. SPY
4. AAPL
5. USB
6. NVDA
7. BA
8. GCTK
9. CFG
10. STT

Go back to Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
(NASDAQ: SKYE) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High $ 
Open $0.63    52 Week Low $ 
Day High $0.66    P/E N/A 
Day Low $0.62    EPS $ 
Volume 97,306